Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study

Author(s):
Bisschop, C.; Dijk, T.H. van; Beukema, J.C.; Jansen, R.L.H.; Gelderblom, H.; Jong, K.P. de; Rutten, H.J.T.; Velde, C.J.H. van de (0000-0003-0104-1800); Wiggers, T.; Havenga, K.; Hospers, G.A.P.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-09-30
Language
English
Is part of
Annals of Surgical Oncology (2017), Vol. 24, no. 9, p. 2632-2638
hdl
1887/94730
doi
10.1245/s10434-017-5897-0